🇺🇸 Humalog Mix 75/25 in United States

FDA authorised Humalog Mix 75/25 on 22 December 1999 · 1,497 US adverse-event reports

Marketing authorisation

FDA — authorised 22 December 1999

  • Application: BLA021017
  • Marketing authorisation holder: LILLY
  • Local brand name: HUMALOG MIX 75/25
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 516 reports (34.47%)
  2. Blood Glucose Decreased — 211 reports (14.09%)
  3. Pharmaceutical Product Complaint — 125 reports (8.35%)
  4. Fall — 113 reports (7.55%)
  5. Hypoglycaemia — 108 reports (7.21%)
  6. Drug Ineffective — 102 reports (6.81%)
  7. Nausea — 82 reports (5.48%)
  8. Malaise — 81 reports (5.41%)
  9. Weight Decreased — 80 reports (5.34%)
  10. Visual Acuity Reduced — 79 reports (5.28%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Humalog Mix 75/25 approved in United States?

Yes. FDA authorised it on 22 December 1999.

Who is the marketing authorisation holder for Humalog Mix 75/25 in United States?

LILLY holds the US marketing authorisation.